Association between diabetes, diabetes treatment and risk of developing endometrial cancer. (Q34283665)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25051408%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

Association between diabetes, diabetes treatment and risk of developing endometrial cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25051408%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25051408%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

J Luo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25051408%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

S Beresford

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25051408%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

C Chen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25051408%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

R Chlebowski

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25051408%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

L Garcia

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25051408%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

L Kuller

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25051408%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

M Regier

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25051408%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

J Wactawski-Wende

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25051408%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

language of work or name

English

0 references

publication date

22 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25051408%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

10 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25051408%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25051408%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

1432-1439

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25051408%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25051408%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bjc.2014.407

10 March 2020

exact match

0 references

cites work

The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Metformin and the risk of endometrial cancer: a case-control analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Insulin resistance: a significant risk factor of endometrial cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Metformin treatment exerts antiinvasive and antimetastatic effects in human endometrial carcinoma cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

LKB1 and AMPK in cell polarity and division

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Diabetes and endometrial cancer: effect modification by body weight, physical activity and hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Diabetes and risk of endometrial cancer: a population-based prospective cohort study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Metformin and reduced risk of cancer in diabetic patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Diabetes mellitus and breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Insulin-like growth factors and neoplasia.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

The women's health initiative observational study: baseline characteristics of participants and reliability of baseline measures

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

The Women's Health Initiative recruitment methods and results

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Epidemiology of endometrial cancer.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Association of Exogenous Estrogen and Endometrial Carcinoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-Analysis

6 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.407

Diabetes mellitus and risk of endometrial cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.407

Graphical methods for assessing violations of the proportional hazards assumption in Cox regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.407

The role of preexisting diabetes mellitus on incidence and mortality of endometrial cancer: a meta-analysis of prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.407

Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

Lifestyle and endometrial cancer risk: a cohort study from the Swedish Twin Registry

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183842

The women's health initiative calcium–vitamin D trial: overview and baseline characteristics of participants

28 October 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.407

Diabetes and endometrial cancer in the Iowa women's health study

21 January 2018

1 reference

12 December 2020

The women's health initiative postmenopausal hormone trials: overview and baseline characteristics of participants

1 reference

12 December 2020

The women's health initiative dietary modification trial: overview and baseline characteristics of participants

1 reference

12 December 2020

Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors

1 reference

12 December 2020

Metformin reverses progestin resistance in endometrial cancer cells by downregulating GloI expression

1 reference

12 December 2020

Self-reported diabetes is a valid outcome in pragmatic clinical trials and observational studies

1 reference

12 December 2020

Design of the Women’s Health Initiative Clinical Trial and Observational Study

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.407

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/BJC.2014.407

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25051408%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

10 March 2020

1050200757

0 references

OpenCitations bibliographic resource ID

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25051408%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25051408%20AND%20SRC:MED&resulttype=core&format=json